The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Wednesday, March 13, 2019
CURE has broadened its DEA license as an authorized manufacturer of Schedule 1 substances to include both cannabis plant extracts and synthetic CBD.
read more
Mylan is conducting a voluntary nationwide recall of two lots of Levoleucovorin Injection, 250 mg/25 mL tothe consumer/user level.
read more
Hospira is voluntarily recalling several lots of Sodium Bicarbonate Injection USP, 50 mEq/50 mL (1 mEq/mL), to the Hospital/Institution level.
read more
Wednesday, March 20, 2019
Nordic Group and Primex Pharmaceuticals AG have announced a strategic agreement today to launch OZALIN® in France.
read more
Candel announced the treatment of the first high grade glioma patients in a study of its GMCI™ in combination with the checkpoint inhibitor nivolumab ...
read more
The FDA approved Zulresso (brexanolone) injection for intravenous (IV) use for the treatment of postpartum depression (PPD) in adult women.
read more
Teva announced the launch of a generic version of EXJADE® (deferasirox) Tablets for Oral Suspension, 125 mg, 250 mg and 500 mg, in the U.S.
read more
Breath Therapeutics announced the initiation of the Phase 3 BOSTON clinical studies of L-CsA-i for the treatment of Bronchiolitis Obliterans Syndrome ...
read more
Biohaven has enrolled the first patient in a Phase 2/3, double-blind, randomized, placebo-controlled, dose-ranging trial of intranasally administered ...
read more
AmEx Pharmacy is voluntarily recalling one Lot of Bevacizumab 1.25mg/0.05mL 31G Injectable to the consumer/user level.
read more
Intec Pharma announced that the last patient has completed their final visit in the Company's trial evaluating the safety and efficacy of the ...
read more
Heron Therapeutics announced it received a CRL from the FDA on April 30, 2019 regarding its New Drug Application for HTX-011 for the management of ...
read more
Sagent Pharmaceuticals announced the voluntary nationwide recall of one lot of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL).
read more
Par Pharmaceutical is voluntarily recalling one lot of Mycophenolate Mofetil for Injection, USP to the hospital and retail pharmacy level.
read more
Regeneron Pharmaceuticals and Sanofi announced that the European Commission approved a new indication for Dupixent® (dupilumab) in asthma.
read more